The Centers for Disease Control and Prevention recently released a report demonstrating the effectiveness of the HPV vaccine in reducing cervical cancer risk. Rates of precancerous lesions among women aged 20 to 24 have plunged by 80%, casting a favorable light on the vaccine’s role in cancer prevention.
